Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Identifieur interne : 000B46 ( Istex/Corpus ); précédent : 000B45; suivant : 000B47

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Auteurs : Neil Pearce ; Nadia Aït-Khaled ; Richard Beasley ; Javier Mallol ; Ulrich Keil ; Ed Mitchell ; Colin Robertson

Source :

RBID : ISTEX:3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79

English descriptors

Abstract

Background: Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time. Methods: The phase I survey was repeated after an interval of 5–10 years in 106 centres in 56 countries in children aged 13–14 years (n = 304 679) and in 66 centres in 37 countries in children aged 6–7 years (n = 193 404). Results: The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13–14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6–7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13–14 years but increased by 0.20% per year in children aged 6–7 years. The corresponding findings per year for the other regions in children aged 13–14 years and 6–7 years, respectively, were: Oceania (−0.39% and −0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (−0.10% and +0.79%); Asia-Pacific (+0.07% and −0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (−0.51% and −0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13–14 year age group and by 0.18% per year in the 6–7 year age group. Conclusions: These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13–14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.

Url:
DOI: 10.1136/thx.2006.070169

Links to Exploration step

ISTEX:3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
<author>
<name sortKey="Pearce, Neil" sort="Pearce, Neil" uniqKey="Pearce N" first="Neil" last="Pearce">Neil Pearce</name>
<affiliation>
<mods:affiliation>Centre for Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department of Biomedical Sciences and Human Oncology, University of Turin, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ait Khaled, Nadia" sort="Ait Khaled, Nadia" uniqKey="Ait Khaled N" first="Nadia" last="Aït-Khaled">Nadia Aït-Khaled</name>
<affiliation>
<mods:affiliation>IUATLD, 68 Bd Saint Michel, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Beasley, Richard" sort="Beasley, Richard" uniqKey="Beasley R" first="Richard" last="Beasley">Richard Beasley</name>
<affiliation>
<mods:affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mallol, Javier" sort="Mallol, Javier" uniqKey="Mallol J" first="Javier" last="Mallol">Javier Mallol</name>
<affiliation>
<mods:affiliation>Department of Pediatric and Respiratory Medicine, University of Santiago de Chile (USACH), Santiago, Chile</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Keil, Ulrich" sort="Keil, Ulrich" uniqKey="Keil U" first="Ulrich" last="Keil">Ulrich Keil</name>
<affiliation>
<mods:affiliation>Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mitchell, Ed" sort="Mitchell, Ed" uniqKey="Mitchell E" first="Ed" last="Mitchell">Ed Mitchell</name>
<affiliation>
<mods:affiliation>Medical and Health Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Robertson, Colin" sort="Robertson, Colin" uniqKey="Robertson C" first="Colin" last="Robertson">Colin Robertson</name>
<affiliation>
<mods:affiliation>Department of Respiratory Medicine, Royal Children’s Hospital, Parkville, Victoria, Australia</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1136/thx.2006.070169</idno>
<idno type="url">https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B46</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B46</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
<author>
<name sortKey="Pearce, Neil" sort="Pearce, Neil" uniqKey="Pearce N" first="Neil" last="Pearce">Neil Pearce</name>
<affiliation>
<mods:affiliation>Centre for Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department of Biomedical Sciences and Human Oncology, University of Turin, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ait Khaled, Nadia" sort="Ait Khaled, Nadia" uniqKey="Ait Khaled N" first="Nadia" last="Aït-Khaled">Nadia Aït-Khaled</name>
<affiliation>
<mods:affiliation>IUATLD, 68 Bd Saint Michel, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Beasley, Richard" sort="Beasley, Richard" uniqKey="Beasley R" first="Richard" last="Beasley">Richard Beasley</name>
<affiliation>
<mods:affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mallol, Javier" sort="Mallol, Javier" uniqKey="Mallol J" first="Javier" last="Mallol">Javier Mallol</name>
<affiliation>
<mods:affiliation>Department of Pediatric and Respiratory Medicine, University of Santiago de Chile (USACH), Santiago, Chile</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Keil, Ulrich" sort="Keil, Ulrich" uniqKey="Keil U" first="Ulrich" last="Keil">Ulrich Keil</name>
<affiliation>
<mods:affiliation>Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mitchell, Ed" sort="Mitchell, Ed" uniqKey="Mitchell E" first="Ed" last="Mitchell">Ed Mitchell</name>
<affiliation>
<mods:affiliation>Medical and Health Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Robertson, Colin" sort="Robertson, Colin" uniqKey="Robertson C" first="Colin" last="Robertson">Colin Robertson</name>
<affiliation>
<mods:affiliation>Department of Respiratory Medicine, Royal Children’s Hospital, Parkville, Victoria, Australia</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Thorax</title>
<title level="j" type="abbrev">Thorax</title>
<idno type="ISSN">0040-6376</idno>
<idno type="eISSN">1468-3296</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher>
<date type="published" when="2007-09">2007-09</date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="758">758</biblScope>
</imprint>
<idno type="ISSN">0040-6376</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0040-6376</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Allergic</term>
<term>Allergic rhinoconjunctivitis</term>
<term>Allergy</term>
<term>Asher</term>
<term>Asthma</term>
<term>Asthma prevalence</term>
<term>Asthma symptom prevalence</term>
<term>Asthma symptoms</term>
<term>Atopic</term>
<term>Atopic eczema</term>
<term>Auckland</term>
<term>Beasley</term>
<term>Centre</term>
<term>Centre report</term>
<term>Chile</term>
<term>Cluster sampling effect</term>
<term>Confidence interval</term>
<term>Costa rica</term>
<term>Current wheeze</term>
<term>Data centre</term>
<term>Eastern europe</term>
<term>Eastern mediterranean</term>
<term>Eczema</term>
<term>English language countries</term>
<term>European community</term>
<term>Health sciences</term>
<term>Health survey</term>
<term>High rates</term>
<term>Hygiene hypothesis</term>
<term>Indian subcontinent</term>
<term>International study</term>
<term>Isaac</term>
<term>Isaac phase</term>
<term>Isaac phases</term>
<term>Keil</term>
<term>Latin america</term>
<term>Little change</term>
<term>Oceania</term>
<term>Pearce</term>
<term>Prevalence</term>
<term>Principal investigators</term>
<term>Public health research</term>
<term>Ranking plot</term>
<term>Respir</term>
<term>Respiratory medicine</term>
<term>Rhinoconjunctivitis</term>
<term>Sample size</term>
<term>Severe asthma</term>
<term>Similar patterns</term>
<term>Subcontinent</term>
<term>Symptom</term>
<term>Symptom prevalence</term>
<term>Time trends</term>
<term>Video</term>
<term>Video questionnaire</term>
<term>Video questionnaires</term>
<term>Wellington</term>
<term>Western europe</term>
<term>Wheeze</term>
<term>Worldwide</term>
<term>Worldwide trends</term>
<term>Worldwide variations</term>
<term>Zealand</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Allergic</term>
<term>Allergic rhinoconjunctivitis</term>
<term>Allergy</term>
<term>Asher</term>
<term>Asthma</term>
<term>Asthma prevalence</term>
<term>Asthma symptom prevalence</term>
<term>Asthma symptoms</term>
<term>Atopic</term>
<term>Atopic eczema</term>
<term>Auckland</term>
<term>Beasley</term>
<term>Centre</term>
<term>Centre report</term>
<term>Chile</term>
<term>Cluster sampling effect</term>
<term>Confidence interval</term>
<term>Costa rica</term>
<term>Current wheeze</term>
<term>Data centre</term>
<term>Eastern europe</term>
<term>Eastern mediterranean</term>
<term>Eczema</term>
<term>English language countries</term>
<term>European community</term>
<term>Health sciences</term>
<term>Health survey</term>
<term>High rates</term>
<term>Hygiene hypothesis</term>
<term>Indian subcontinent</term>
<term>International study</term>
<term>Isaac</term>
<term>Isaac phase</term>
<term>Isaac phases</term>
<term>Keil</term>
<term>Latin america</term>
<term>Little change</term>
<term>Oceania</term>
<term>Pearce</term>
<term>Prevalence</term>
<term>Principal investigators</term>
<term>Public health research</term>
<term>Ranking plot</term>
<term>Respir</term>
<term>Respiratory medicine</term>
<term>Rhinoconjunctivitis</term>
<term>Sample size</term>
<term>Severe asthma</term>
<term>Similar patterns</term>
<term>Subcontinent</term>
<term>Symptom</term>
<term>Symptom prevalence</term>
<term>Time trends</term>
<term>Video</term>
<term>Video questionnaire</term>
<term>Video questionnaires</term>
<term>Wellington</term>
<term>Western europe</term>
<term>Wheeze</term>
<term>Worldwide</term>
<term>Worldwide trends</term>
<term>Worldwide variations</term>
<term>Zealand</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time. Methods: The phase I survey was repeated after an interval of 5–10 years in 106 centres in 56 countries in children aged 13–14 years (n = 304 679) and in 66 centres in 37 countries in children aged 6–7 years (n = 193 404). Results: The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13–14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6–7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13–14 years but increased by 0.20% per year in children aged 6–7 years. The corresponding findings per year for the other regions in children aged 13–14 years and 6–7 years, respectively, were: Oceania (−0.39% and −0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (−0.10% and +0.79%); Asia-Pacific (+0.07% and −0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (−0.51% and −0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13–14 year age group and by 0.18% per year in the 6–7 year age group. Conclusions: These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13–14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.</div>
</front>
</TEI>
<istex>
<corpusName>bmj</corpusName>
<keywords>
<teeft>
<json:string>asthma</json:string>
<json:string>wheeze</json:string>
<json:string>allergy</json:string>
<json:string>current wheeze</json:string>
<json:string>centre</json:string>
<json:string>prevalence</json:string>
<json:string>asthma symptoms</json:string>
<json:string>international study</json:string>
<json:string>western europe</json:string>
<json:string>symptom prevalence</json:string>
<json:string>english language countries</json:string>
<json:string>pearce</json:string>
<json:string>eczema</json:string>
<json:string>little change</json:string>
<json:string>latin america</json:string>
<json:string>eastern europe</json:string>
<json:string>isaac phase</json:string>
<json:string>beasley</json:string>
<json:string>atopic</json:string>
<json:string>respir</json:string>
<json:string>time trends</json:string>
<json:string>video questionnaire</json:string>
<json:string>ranking plot</json:string>
<json:string>sample size</json:string>
<json:string>indian subcontinent</json:string>
<json:string>eastern mediterranean</json:string>
<json:string>cluster sampling effect</json:string>
<json:string>rhinoconjunctivitis</json:string>
<json:string>allergic rhinoconjunctivitis</json:string>
<json:string>keil</json:string>
<json:string>confidence interval</json:string>
<json:string>symptom</json:string>
<json:string>auckland</json:string>
<json:string>health sciences</json:string>
<json:string>asthma symptom prevalence</json:string>
<json:string>severe asthma</json:string>
<json:string>oceania</json:string>
<json:string>worldwide</json:string>
<json:string>public health research</json:string>
<json:string>asthma prevalence</json:string>
<json:string>wellington</json:string>
<json:string>asher</json:string>
<json:string>subcontinent</json:string>
<json:string>zealand</json:string>
<json:string>video</json:string>
<json:string>respiratory medicine</json:string>
<json:string>atopic eczema</json:string>
<json:string>video questionnaires</json:string>
<json:string>european community</json:string>
<json:string>health survey</json:string>
<json:string>worldwide trends</json:string>
<json:string>chile</json:string>
<json:string>hygiene hypothesis</json:string>
<json:string>high rates</json:string>
<json:string>isaac phases</json:string>
<json:string>principal investigators</json:string>
<json:string>costa rica</json:string>
<json:string>centre report</json:string>
<json:string>worldwide variations</json:string>
<json:string>similar patterns</json:string>
<json:string>data centre</json:string>
<json:string>isaac</json:string>
<json:string>allergic</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Neil Pearce</name>
<affiliations>
<json:string>Centre for Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department of Biomedical Sciences and Human Oncology, University of Turin, Italy</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nadia Aït-Khaled</name>
<affiliations>
<json:string>IUATLD, 68 Bd Saint Michel, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Richard Beasley</name>
<affiliations>
<json:string>Medical Research Institute of New Zealand, Wellington, New Zealand</json:string>
</affiliations>
</json:item>
<json:item>
<name>Javier Mallol</name>
<affiliations>
<json:string>Department of Pediatric and Respiratory Medicine, University of Santiago de Chile (USACH), Santiago, Chile</json:string>
</affiliations>
</json:item>
<json:item>
<name>Ulrich Keil</name>
<affiliations>
<json:string>Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Ed Mitchell</name>
<affiliations>
<json:string>Medical and Health Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand</json:string>
</affiliations>
</json:item>
<json:item>
<name>Colin Robertson</name>
<affiliations>
<json:string>Department of Respiratory Medicine, Royal Children’s Hospital, Parkville, Victoria, Australia</json:string>
</affiliations>
</json:item>
</author>
<arkIstex>ark:/67375/NVC-K72S3LVJ-Q</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>other</json:string>
</originalGenre>
<abstract>Background: Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time. Methods: The phase I survey was repeated after an interval of 5–10 years in 106 centres in 56 countries in children aged 13–14 years (n = 304 679) and in 66 centres in 37 countries in children aged 6–7 years (n = 193 404). Results: The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13–14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6–7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13–14 years but increased by 0.20% per year in children aged 6–7 years. The corresponding findings per year for the other regions in children aged 13–14 years and 6–7 years, respectively, were: Oceania (−0.39% and −0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (−0.10% and +0.79%); Asia-Pacific (+0.07% and −0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (−0.51% and −0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13–14 year age group and by 0.18% per year in the 6–7 year age group. Conclusions: These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13–14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.</abstract>
<qualityIndicators>
<score>10</score>
<pdfWordCount>6990</pdfWordCount>
<pdfCharCount>45494</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>9</pdfPageCount>
<pdfPageSize>595.276 x 793.701 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>425</abstractWordCount>
<abstractCharCount>2707</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
<pmid>
<json:string>17504817</json:string>
</pmid>
<genre>
<json:string>other</json:string>
</genre>
<host>
<title>Thorax</title>
<language>
<json:string>unknown</json:string>
</language>
<issn>
<json:string>0040-6376</json:string>
</issn>
<eissn>
<json:string>1468-3296</json:string>
</eissn>
<volume>62</volume>
<issue>9</issue>
<pages>
<first>758</first>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Editor's choice</value>
</json:item>
<json:item>
<value>Child health</value>
</json:item>
<json:item>
<value>Asthma</value>
</json:item>
</subject>
</host>
<namedEntities>
<unitex>
<date>
<json:string>1950s</json:string>
<json:string>2007-05-15</json:string>
<json:string>3000</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Health Research Council of New Zealand, the Asthma and Respiratory Foundation</json:string>
<json:string>India, Albania</json:string>
<json:string>Albania, Greece, China, Taiwan, Uzbekistan, India, Indonesia and Ethiopia</json:string>
<json:string>University of Santiago</json:string>
<json:string>Italy Nadia A</json:string>
<json:string>Singapore and Japan</json:string>
<json:string>Medical Research Institute of New Zealand, Wellington, New Zealand Javier Mallol, Department of Pediatric and Respiratory Medicine</json:string>
<json:string>New Zealand Colin Robertson, Department of Respiratory Medicine, Royal Children</json:string>
<json:string>Spain and Portugal</json:string>
<json:string>Barbados, Tunisia, Morocco and Algeria</json:string>
<json:string>Algeria and Tunisia</json:string>
<json:string>University of Auckland</json:string>
<json:string>University of Turin</json:string>
<json:string>UK, Australia, New Zealand</json:string>
<json:string>Morocco, Worldwide</json:string>
<json:string>Bay Medical Research Foundation, the Waikato Medical Research Foundation, Glaxo Wellcome New Zealand, the NZ Lottery Board</json:string>
<json:string>Australia, Canada, Channel Islands, Isle of Man, New Zealand, Republic of Ireland, UK, USA</json:string>
<json:string>China, Indonesia, Taiwan and South Korea</json:string>
<json:string>Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department</json:string>
<json:string>Costa Rica, Panama, Mexico, Argentina and Chile</json:string>
<json:string>Indonesia and China</json:string>
<json:string>Chile Ulrich Keil, Institut</json:string>
<json:string>Health Research Council of New Zealand</json:string>
<json:string>Neil Pearce</json:string>
<json:string>Progetto Lagrange</json:string>
<json:string>Fondazione CRT</json:string>
<json:string>New Zealand</json:string>
</orgName>
<orgName_funder>
<json:string>Health Research Council of New Zealand</json:string>
<json:string>Neil Pearce</json:string>
<json:string>Progetto Lagrange</json:string>
<json:string>Fondazione CRT</json:string>
<json:string>New Zealand</json:string>
</orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>ISAAC Phase</json:string>
<json:string>Ed Mitchell</json:string>
<json:string>Richard Beasley</json:string>
<json:string>Europe</json:string>
<json:string>Javier Mallol</json:string>
<json:string>Neil Pearce</json:string>
<json:string>Ulrich Keil</json:string>
<json:string>America</json:string>
</persName>
<placeName>
<json:string>Paris</json:string>
<json:string>Germany</json:string>
<json:string>Saint Michel</json:string>
<json:string>Australia</json:string>
<json:string>Chile</json:string>
<json:string>Barbados</json:string>
<json:string>Romania</json:string>
<json:string>Victoria</json:string>
<json:string>India</json:string>
<json:string>China</json:string>
<json:string>Europe</json:string>
<json:string>America</json:string>
<json:string>Auckland</json:string>
<json:string>New Zealand</json:string>
<json:string>Ireland</json:string>
<json:string>France</json:string>
</placeName>
<ref_url>
<json:string>http://thorax.bmj.com/supplemental</json:string>
</ref_url>
<ref_bibl>
<json:string>Marcos et al</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/NVC-K72S3LVJ-Q</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - respiratory system</json:string>
</wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - respiratory system</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Pulmonary and Respiratory Medicine</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>2007</publicationDate>
<copyrightDate>2007</copyrightDate>
<doi>
<json:string>10.1136/thx.2006.070169</json:string>
</doi>
<id>3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher scheme="https://publisher-list.data.istex.fr">BMJ Publishing Group Ltd and British Thoracic Society</publisher>
<availability>
<licence>
<p>Copyright 2007 Thorax</p>
</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</p>
</availability>
<date>2007-05-15</date>
</publicationStmt>
<notesStmt>
<note type="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
<note>Correspondence to:
 Professor Neil Pearce
 Centre for Public Health Research, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand; n.e.pearce@massey.ac.nz</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
<author xml:id="author-0000">
<persName>
<forename type="first">Neil</forename>
<surname>Pearce</surname>
</persName>
<affiliation>Centre for Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department of Biomedical Sciences and Human Oncology, University of Turin, Italy</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Nadia</forename>
<surname>Aït-Khaled</surname>
</persName>
<affiliation>IUATLD, 68 Bd Saint Michel, Paris, France</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">Richard</forename>
<surname>Beasley</surname>
</persName>
<affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">Javier</forename>
<surname>Mallol</surname>
</persName>
<affiliation>Department of Pediatric and Respiratory Medicine, University of Santiago de Chile (USACH), Santiago, Chile</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">Ulrich</forename>
<surname>Keil</surname>
</persName>
<affiliation>Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Germany</affiliation>
</author>
<author xml:id="author-0005">
<persName>
<forename type="first">Ed</forename>
<surname>Mitchell</surname>
</persName>
<affiliation>Medical and Health Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand</affiliation>
</author>
<author xml:id="author-0006">
<persName>
<forename type="first">Colin</forename>
<surname>Robertson</surname>
</persName>
<affiliation>Department of Respiratory Medicine, Royal Children’s Hospital, Parkville, Victoria, Australia</affiliation>
</author>
<idno type="istex">3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79</idno>
<idno type="ark">ark:/67375/NVC-K72S3LVJ-Q</idno>
<idno type="DOI">10.1136/thx.2006.070169</idno>
<idno type="href">thoraxjnl-62-758.pdf</idno>
<idno type="PMID">17504817</idno>
<idno type="local">0620758</idno>
</analytic>
<monogr>
<title level="j">Thorax</title>
<title level="j" type="abbrev">Thorax</title>
<idno type="pISSN">0040-6376</idno>
<idno type="eISSN">1468-3296</idno>
<idno type="PublisherID-hwp">thoraxjnl</idno>
<idno type="PublisherID-nlm-ta">Thorax</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher>
<date type="published" when="2007-09"></date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="758">758</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2007-05-15</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Background: Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time. Methods: The phase I survey was repeated after an interval of 5–10 years in 106 centres in 56 countries in children aged 13–14 years (n = 304 679) and in 66 centres in 37 countries in children aged 6–7 years (n = 193 404). Results: The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13–14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6–7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13–14 years but increased by 0.20% per year in children aged 6–7 years. The corresponding findings per year for the other regions in children aged 13–14 years and 6–7 years, respectively, were: Oceania (−0.39% and −0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (−0.10% and +0.79%); Asia-Pacific (+0.07% and −0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (−0.51% and −0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13–14 year age group and by 0.18% per year in the 6–7 year age group. Conclusions: These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13–14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.</p>
</abstract>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>hwp-journal-coll</head>
<item>
<term>Editor's choice</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>hwp-journal-coll</head>
<item>
<term>Child health</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>hwp-journal-coll</head>
<item>
<term>Asthma</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2007-05-15">Created</change>
<change when="2007-09">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType>
<istex:document>
<article xml:lang="en" article-type="other">
<front>
<journal-meta>
<journal-id journal-id-type="hwp">thoraxjnl</journal-id>
<journal-id journal-id-type="nlm-ta">Thorax</journal-id>
<journal-title>Thorax</journal-title>
<abbrev-journal-title abbrev-type="publisher">Thorax</abbrev-journal-title>
<issn pub-type="ppub">0040-6376</issn>
<issn pub-type="epub">1468-3296</issn>
<publisher>
<publisher-name>BMJ Publishing Group Ltd and British Thoracic Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="other">0620758</article-id>
<article-id pub-id-type="doi">10.1136/thx.2006.070169</article-id>
<article-id pub-id-type="other">thoraxjnl;62/9/758</article-id>
<article-id pub-id-type="other">thoraxjnl;thx.2006.070169</article-id>
<article-id pub-id-type="pmid">17504817</article-id>
<article-id pub-id-type="other">758</article-id>
<article-id pub-id-type="other">thx.2006.070169</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Asthma</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Editor's choice</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Child health</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Asthma</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Pearce</surname>
<given-names>Neil</given-names>
</name>
<xref rid="AFF1">1</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Aït-Khaled</surname>
<given-names>Nadia</given-names>
</name>
<xref rid="AFF2">2</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Beasley</surname>
<given-names>Richard</given-names>
</name>
<xref rid="AFF3">3</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mallol</surname>
<given-names>Javier</given-names>
</name>
<xref rid="AFF4">4</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Keil</surname>
<given-names>Ulrich</given-names>
</name>
<xref rid="AFF5">5</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mitchell</surname>
<given-names>Ed</given-names>
</name>
<xref rid="AFF6">6</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Robertson</surname>
<given-names>Colin</given-names>
</name>
<xref rid="AFF7">7</xref>
</contrib>
<contrib contrib-type="group-author" xlink:type="simple">
<on-behalf-of>and the ISAAC Phase Three Study Group</on-behalf-of>
</contrib>
<aff id="AFF1">
<label>1</label>
Centre for Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department of Biomedical Sciences and Human Oncology, University of Turin, Italy</aff>
<aff id="AFF2">
<label>2</label>
IUATLD, 68 Bd Saint Michel, Paris, France</aff>
<aff id="AFF3">
<label>3</label>
Medical Research Institute of New Zealand, Wellington, New Zealand</aff>
<aff id="AFF4">
<label>4</label>
Department of Pediatric and Respiratory Medicine, University of Santiago de Chile (USACH), Santiago, Chile</aff>
<aff id="AFF5">
<label>5</label>
Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Germany</aff>
<aff id="AFF6">
<label>6</label>
Medical and Health Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand</aff>
<aff id="AFF7">
<label>7</label>
Department of Respiratory Medicine, Royal Children’s Hospital, Parkville, Victoria, Australia</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence to:
 Professor Neil Pearce
 Centre for Public Health Research, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand;
<ext-link xlink:href="n.e.pearce@massey.ac.nz" ext-link-type="email" xlink:type="simple">n.e.pearce@massey.ac.nz</ext-link>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>5</month>
<year>2007</year>
</pub-date>
<volume>62</volume>
<volume-id pub-id-type="other">62</volume-id>
<volume-id pub-id-type="other">62</volume-id>
<issue>9</issue>
<issue-id pub-id-type="other">thoraxjnl;62/9</issue-id>
<issue-id pub-id-type="other">9</issue-id>
<issue-id pub-id-type="other">62/9</issue-id>
<fpage>758</fpage>
<history>
<date date-type="accepted">
<day>26</day>
<month>02</month>
<year>2007</year>
</date>
<date date-type="received">
<day>24</day>
<month>09</month>
<year>2006</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright 2007 Thorax</copyright-statement>
<copyright-year>2007</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:role="full-text" xlink:href="thoraxjnl-62-758.pdf"></self-uri>
<abstract xml:lang="en">
<p>
<bold>Background:</bold>
Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time.</p>
<p>
<bold>Methods:</bold>
The phase I survey was repeated after an interval of 5–10 years in 106 centres in 56 countries in children aged 13–14 years (n = 304 679) and in 66 centres in 37 countries in children aged 6–7 years (n = 193 404).</p>
<p>
<bold>Results:</bold>
The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13–14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6–7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13–14 years but increased by 0.20% per year in children aged 6–7 years. The corresponding findings per year for the other regions in children aged 13–14 years and 6–7 years, respectively, were: Oceania (−0.39% and −0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (−0.10% and +0.79%); Asia-Pacific (+0.07% and −0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (−0.51% and −0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13–14 year age group and by 0.18% per year in the 6–7 year age group.</p>
<p>
<bold>Conclusions:</bold>
These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13–14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.</p>
</abstract>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)</title>
</titleInfo>
<name type="personal">
<namePart type="given">Neil</namePart>
<namePart type="family">Pearce</namePart>
<affiliation>Centre for Public Health Research, Massey University Wellington Campus, Wellington, New Zealand and Department of Biomedical Sciences and Human Oncology, University of Turin, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nadia</namePart>
<namePart type="family">Aït-Khaled</namePart>
<affiliation>IUATLD, 68 Bd Saint Michel, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Richard</namePart>
<namePart type="family">Beasley</namePart>
<affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Javier</namePart>
<namePart type="family">Mallol</namePart>
<affiliation>Department of Pediatric and Respiratory Medicine, University of Santiago de Chile (USACH), Santiago, Chile</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Ulrich</namePart>
<namePart type="family">Keil</namePart>
<affiliation>Institut für Epidemiologie und Sozialmedizin, Universität Münster, Münster, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Ed</namePart>
<namePart type="family">Mitchell</namePart>
<affiliation>Medical and Health Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Colin</namePart>
<namePart type="family">Robertson</namePart>
<affiliation>Department of Respiratory Medicine, Royal Children’s Hospital, Parkville, Victoria, Australia</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="other" displayLabel="other" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre>
<originInfo>
<publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher>
<dateIssued encoding="w3cdtf">2007-09</dateIssued>
<dateCreated encoding="w3cdtf">2007-05-15</dateCreated>
<copyrightDate encoding="w3cdtf">2007</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract lang="en">Background: Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to allow worldwide comparisons of the prevalence of asthma symptoms. In phase III the phase I survey was repeated in order to assess changes over time. Methods: The phase I survey was repeated after an interval of 5–10 years in 106 centres in 56 countries in children aged 13–14 years (n = 304 679) and in 66 centres in 37 countries in children aged 6–7 years (n = 193 404). Results: The mean symptom prevalence of current wheeze in the last 12 months changed slightly from 13.2% to 13.7% in the 13–14 year age group (mean increase of 0.06% per year) and from 11.1% to 11.6% in the 6–7 year age group (mean increase of 0.13% per year). There was also little change in the mean symptom prevalence of severe asthma or the symptom prevalence measured with the asthma video questionnaire. However, the time trends in asthma symptom prevalence showed different regional patterns. In Western Europe, current wheeze decreased by 0.07% per year in children aged 13–14 years but increased by 0.20% per year in children aged 6–7 years. The corresponding findings per year for the other regions in children aged 13–14 years and 6–7 years, respectively, were: Oceania (−0.39% and −0.21%); Latin America (+0.32% and +0.07%); Northern and Eastern Europe (+0.26% and +0.05%); Africa (+0.16% and +0.10%); North America (+0.12% and +0.32%); Eastern Mediterranean (−0.10% and +0.79%); Asia-Pacific (+0.07% and −0.06%); and the Indian subcontinent (+0.02% and +0.06%). There was a particularly marked reduction in current asthma symptom prevalence in English language countries (−0.51% and −0.09%). Similar patterns were observed for symptoms of severe asthma. However, the percentage of children reported to have had asthma at some time in their lives increased by 0.28% per year in the 13–14 year age group and by 0.18% per year in the 6–7 year age group. Conclusions: These findings indicate that international differences in asthma symptom prevalence have reduced, particularly in the 13–14 year age group, with decreases in prevalence in English speaking countries and Western Europe and increases in prevalence in regions where prevalence was previously low. Although there was little change in the overall prevalence of current wheeze, the percentage of children reported to have had asthma increased significantly, possibly reflecting greater awareness of this condition and/or changes in diagnostic practice. The increases in asthma symptom prevalence in Africa, Latin America and parts of Asia indicate that the global burden of asthma is continuing to rise, but the global prevalence differences are lessening.</abstract>
<note type="author-notes">Correspondence to:
 Professor Neil Pearce
 Centre for Public Health Research, Massey University Wellington Campus, Private Box 756, Wellington, New Zealand; n.e.pearce@massey.ac.nz</note>
<relatedItem type="host">
<titleInfo>
<title>Thorax</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Thorax</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject>
<genre>hwp-journal-coll</genre>
<topic>Editor's choice</topic>
</subject>
<subject>
<genre>hwp-journal-coll</genre>
<topic>Child health</topic>
</subject>
<subject>
<genre>hwp-journal-coll</genre>
<topic>Asthma</topic>
</subject>
<identifier type="ISSN">0040-6376</identifier>
<identifier type="eISSN">1468-3296</identifier>
<identifier type="PublisherID-hwp">thoraxjnl</identifier>
<identifier type="PublisherID-nlm-ta">Thorax</identifier>
<part>
<date>2007</date>
<detail type="volume">
<caption>vol.</caption>
<number>62</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>9</number>
</detail>
<extent unit="pages">
<start>758</start>
</extent>
</part>
</relatedItem>
<identifier type="istex">3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79</identifier>
<identifier type="ark">ark:/67375/NVC-K72S3LVJ-Q</identifier>
<identifier type="DOI">10.1136/thx.2006.070169</identifier>
<identifier type="href">thoraxjnl-62-758.pdf</identifier>
<identifier type="PMID">17504817</identifier>
<identifier type="local">0620758</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright 2007 Thorax</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</recordContentSource>
<recordOrigin>Copyright 2007 Thorax</recordOrigin>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/metadata/json</uri>
</json:item>
</metadata>
<annexes>
<json:item>
<extension>jpeg</extension>
<original>true</original>
<mimetype>image/jpeg</mimetype>
<uri>https://api.istex.fr/document/3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79/annexes/jpeg</uri>
</json:item>
</annexes>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B46 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B46 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:3CF465B8D773CFE34F9FBFFBD8CEEA797EFD1B79
   |texte=   Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024